ACLX
Price
$66.48
Change
-$0.53 (-0.79%)
Updated
Jan 17 closing price
Capitalization
3.59B
61 days until earnings call
LRMR
Price
$3.34
Change
+$0.09 (+2.77%)
Updated
Jan 17 closing price
Capitalization
213.11M
53 days until earnings call
Ad is loading...

ACLX vs LRMR

Header iconACLX vs LRMR Comparison
Open Charts ACLX vs LRMRBanner chart's image
Arcellx
Price$66.48
Change-$0.53 (-0.79%)
Volume$562.47K
Capitalization3.59B
Larimar Therapeutics
Price$3.34
Change+$0.09 (+2.77%)
Volume$527.36K
Capitalization213.11M
ACLX vs LRMR Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. LRMR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and LRMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ACLX: $66.48 vs. LRMR: $3.34)
Brand notoriety: ACLX and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 95% vs. LRMR: 62%
Market capitalization -- ACLX: $3.59B vs. LRMR: $213.11M
ACLX [@Biotechnology] is valued at $3.59B. LRMR’s [@Biotechnology] market capitalization is $213.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • LRMR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -3.76% price change this week, while LRMR (@Biotechnology) price change was -8.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

LRMR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.6B) has a higher market cap than LRMR($213M). ACLX (-13.313) and LRMR (-13.695) have similar YTD gains . ACLX has higher annual earnings (EBITDA): -33.12M vs. LRMR (-73.44M). ACLX has more cash in the bank: 574M vs. LRMR (204M). LRMR has less debt than ACLX: LRMR (5.36M) vs ACLX (65.3M). ACLX has higher revenues than LRMR: ACLX (156M) vs LRMR (0).
ACLXLRMRACLX / LRMR
Capitalization3.6B213M1,688%
EBITDA-33.12M-73.44M45%
Gain YTD-13.313-13.69597%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M204M281%
Total Debt65.3M5.36M1,218%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXLRMR
RSI
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
72%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
89%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
82%
Aroon
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.79%
DNLI - ACLX
49%
Loosely correlated
+1.20%
KYMR - ACLX
48%
Loosely correlated
+0.79%
RCUS - ACLX
47%
Loosely correlated
-0.64%
BEAM - ACLX
46%
Loosely correlated
+0.17%
RCKT - ACLX
46%
Loosely correlated
+0.98%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+2.77%
SVRA - LRMR
42%
Loosely correlated
+0.69%
ABSI - LRMR
38%
Loosely correlated
+3.57%
TRDA - LRMR
37%
Loosely correlated
+1.20%
ACLX - LRMR
36%
Loosely correlated
-0.79%
SLDB - LRMR
36%
Loosely correlated
+0.62%
More